Tharimmune, Inc. (THAR)

NASDAQ

$--

(--)

Pre-Market

Tharimmune, Inc. (THAR) Live Price Chart

Last updated: ⁦2026-10-20 09:39:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Tharimmune, Inc. (THAR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Tharimmune, Inc. (THAR) Pre-Market Stock Price

Tharimmune, Inc. (THAR) is trading at $-- in pre-market trading as of --, -- from the previous close of $--

Pre-market trading shows how investors are pricing THAR before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.

Tharimmune, Inc. (THAR) 7-Day Stock Price Change

Over the past seven days, Tharimmune, Inc. (THAR) moved from $4.16 to $4.74, representing a gain of 13.94% ($0.58).

The stock traded between $3.82 and $4.83 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 812.18 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

What is Tharimmune, Inc. (THAR)?

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Tharimmune, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	3
Exchange	NASDAQ
Company Website	https://www.hillstreambio.com

How to Buy Tharimmune, Inc. (THAR) Stock on MEXC

Eligible investors can buy real shares of Tharimmune, Inc. (THAR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for THAR and Place Your Order

Open the RealStocks trading page and search for THAR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Tharimmune, Inc. (THAR) stock price today?

Tharimmune, Inc. (THAR) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is THAR stock going up or down today?

As of --, THAR is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is THAR pre-market price?

As of --, THAR is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is THAR after-hours price?

As of --, THAR is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is THAR stock trading now?

THAR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does THAR sit relative to its 52-week high and low?

Over the past 52 weeks, THAR has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Tharimmune, Inc. in?

Tharimmune, Inc. (THAR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Tharimmune, Inc.'s market capitalization and where is it listed?

Tharimmune, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is THAR valued in terms of P/E ratio and EPS?

THAR trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Tharimmune, Inc. pay a dividend?

Tharimmune, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.